Birdwatch Note
2024-08-13 22:00:03 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
動画が触れている抗原特異的Tregは舌下免疫療法等で働く事が知られている細胞ですが https://bibgraph.hpcr.jp/abst/pubmed/31109864?click_by=rel_abst メジャーながんである非小細胞肺がん、大腸がんのステージ４の年間登録数はそれぞれ下記で 2017:25494 17099 2018:25257 17543 2019:26259 18639 2020:25809 18399 2021:26431 19379 2022:25822 18836 まず、動画が論じるているようながん一般での転移癌が過年度の傾向から逸脱して増えているというような事実からして存在しない事に注意が必要です 出典 下記で臨床病期と全施設と年を選択 https://jhcr-cs.ganjoho.jp/hbcrtables/wpCancerSearch.aspx?UnitType=1
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1823389847429828909
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1823479655070151019
- noteId - 1823479655070151019
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1723586403040
- tweetId - 1823389847429828909
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 動画が触れている抗原特異的Tregは舌下免疫療法等で働く事が知られている細胞ですが https://bibgraph.hpcr.jp/abst/pubmed/31109864?click_by=rel_abst メジャーながんである非小細胞肺がん、大腸がんのステージ４の年間登録数はそれぞれ下記で 2017:25494 17099 2018:25257 17543 2019:26259 18639 2020:25809 18399 2021:26431 19379 2022:25822 18836 まず、動画が論じるているようながん一般での転移癌が過年度の傾向から逸脱して増えているというような事実からして存在しない事に注意が必要です 出典 下記で臨床病期と全施設と年を選択 https://jhcr-cs.ganjoho.jp/hbcrtables/wpCancerSearch.aspx?UnitType=1
Note Ratings
| rated at | rated by | |
| 2024-08-16 07:26:50 -0500 | Rating Details | |
| 2024-08-15 23:27:45 -0500 | Rating Details | |
| 2024-08-15 18:52:51 -0500 | Rating Details | |
| 2024-08-15 06:00:00 -0500 | Rating Details | |
| 2024-08-14 18:59:55 -0500 | Rating Details | |
| 2024-08-14 06:35:24 -0500 | Rating Details | |
| 2024-08-14 05:52:05 -0500 | Rating Details | |
| 2024-08-14 05:43:02 -0500 | Rating Details | |
| 2024-08-14 01:56:26 -0500 | Rating Details | |
| 2024-08-14 01:48:57 -0500 | Rating Details | |
| 2024-08-14 01:31:33 -0500 | Rating Details | |
| 2024-08-14 01:06:43 -0500 | Rating Details | |
| 2024-08-14 00:34:39 -0500 | Rating Details | |
| 2024-08-14 00:24:07 -0500 | Rating Details | |
| 2024-08-14 00:24:07 -0500 | Rating Details | |
| 2024-08-14 00:09:47 -0500 | Rating Details | |
| 2024-08-13 23:52:35 -0500 | Rating Details | |
| 2024-08-13 23:52:11 -0500 | Rating Details | |
| 2024-08-13 23:48:48 -0500 | Rating Details | |
| 2024-08-13 23:35:05 -0500 | Rating Details | |
| 2024-08-13 23:17:09 -0500 | Rating Details | |
| 2024-08-13 23:11:07 -0500 | Rating Details | |
| 2024-08-13 22:59:09 -0500 | Rating Details | |
| 2024-08-13 22:59:03 -0500 | Rating Details | |
| 2024-08-13 22:51:11 -0500 | Rating Details | |
| 2024-08-13 22:44:20 -0500 | Rating Details | |
| 2024-08-13 22:32:13 -0500 | Rating Details | |
| 2024-08-13 22:30:05 -0500 | Rating Details | |
| 2024-08-13 22:21:05 -0500 | Rating Details | |
| 2024-08-13 22:14:25 -0500 | Rating Details | |
| 2024-08-13 22:08:00 -0500 | Rating Details | |
| 2024-08-13 22:05:17 -0500 | Rating Details | |
| 2024-08-13 22:00:28 -0500 | Rating Details | |
| 2024-08-13 21:56:36 -0500 | Rating Details | |
| 2024-08-13 21:44:37 -0500 | Rating Details | |
| 2024-08-13 21:39:04 -0500 | Rating Details | |
| 2024-08-13 21:28:16 -0500 | Rating Details | |
| 2024-08-13 21:25:26 -0500 | Rating Details | |
| 2024-08-13 21:13:42 -0500 | Rating Details | |
| 2024-08-13 20:20:22 -0500 | Rating Details | |
| 2024-08-13 20:13:14 -0500 | Rating Details | |
| 2024-08-13 19:29:16 -0500 | Rating Details | |
| 2024-08-13 19:28:35 -0500 | Rating Details | |
| 2024-08-13 19:25:55 -0500 | Rating Details | |
| 2024-08-13 19:25:49 -0500 | Rating Details | |
| 2024-08-13 19:05:33 -0500 | Rating Details | |
| 2024-08-13 19:02:01 -0500 | Rating Details | |
| 2024-08-13 19:01:45 -0500 | Rating Details | |
| 2024-08-13 18:52:03 -0500 | Rating Details | |
| 2024-08-13 18:51:23 -0500 | Rating Details | |
| 2024-08-13 18:50:14 -0500 | Rating Details | |
| 2024-08-13 18:48:32 -0500 | Rating Details | |
| 2024-08-13 18:38:14 -0500 | Rating Details | |
| 2024-08-13 18:21:42 -0500 | Rating Details | |
| 2024-08-13 18:15:45 -0500 | Rating Details | |
| 2024-08-13 18:13:23 -0500 | Rating Details | |
| 2024-08-13 18:09:41 -0500 | Rating Details | |
| 2024-08-13 18:09:02 -0500 | Rating Details | |
| 2024-08-13 18:02:16 -0500 | Rating Details | |
| 2024-08-13 18:01:46 -0500 | Rating Details | |
| 2024-08-13 17:57:11 -0500 | Rating Details | |
| 2024-08-13 17:55:54 -0500 | Rating Details | |
| 2024-08-13 17:53:54 -0500 | Rating Details | |
| 2024-08-13 17:44:01 -0500 | Rating Details | |
| 2024-08-13 17:41:25 -0500 | Rating Details | |
| 2024-08-13 17:22:53 -0500 | Rating Details | |
| 2024-08-13 17:20:34 -0500 | Rating Details | |
| 2024-08-15 13:46:36 -0500 | Rating Details | |
| 2024-08-14 01:54:24 -0500 | Rating Details | |
| 2024-08-13 23:28:16 -0500 | Rating Details | |
| 2024-08-13 22:46:41 -0500 | Rating Details | |
| 2024-08-13 21:26:42 -0500 | Rating Details | |
| 2024-08-13 20:37:27 -0500 | Rating Details | |
| 2024-08-13 20:22:54 -0500 | Rating Details | |
| 2024-08-13 20:04:31 -0500 | Rating Details | |
| 2024-08-13 19:56:29 -0500 | Rating Details | |
| 2024-08-13 19:17:37 -0500 | Rating Details | |
| 2024-08-13 19:09:16 -0500 | Rating Details | |
| 2024-08-13 19:04:22 -0500 | Rating Details | |
| 2024-08-13 18:19:39 -0500 | Rating Details | |
| 2024-08-13 18:05:32 -0500 | Rating Details | |
| 2024-08-13 18:00:36 -0500 | Rating Details | |
| 2024-08-13 17:49:46 -0500 | Rating Details | |
| 2024-08-13 17:45:15 -0500 | Rating Details | |
| 2024-08-13 17:15:37 -0500 | Rating Details | |
| 2024-08-13 17:06:01 -0500 | Rating Details |